Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAMIS PHARMACEUTICALS CORPORATION

(ADMP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 10643,245,4153--
Entreprise Value (EV)1 10643,245,4153153153
P/E ratio -2,25x-1,27x-0,76x-6,06x-7,63x-14,7x
Yield ------
Capitalization / Revenue 7,05x1,95x2,75x6,97x7,23x5,59x
EV / Revenue 7,05x1,95x2,75x6,97x7,23x5,59x
EV / EBITDA -2 926 056x-----
Price to Book ------
Nbr of stocks (in thousands) 47 29161 63493 658148 886--
Reference price (USD) 2,250,700,491,031,031,03
Last update 03/15/201903/30/202004/15/2021---
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 15,122,116,522,021,227,4
EBITDA -36,4-----
Operating profit (EBIT)1 -39,5-29,0-49,8-23,9-18,5-11,8
Operating Margin -262%-131%-301%-109%-87,0%-43,0%
Pre-Tax Profit (EBT)1 -39,4-29,3-49,4-24,0-18,5-11,8
Net income1 -39,0-29,3-49,4-24,0-18,5-11,8
Net margin -259%-133%-299%-109%-87,4%-43,0%
EPS2 -1,00-0,55-0,64-0,17-0,14-0,07
Dividend per Share ------
Last update 03/15/201903/30/202004/15/2021---
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow -36,2-----
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex ------
Capex / Sales ------
Last update 03/15/201903/30/202004/15/202106/09/202106/09/202104/16/2021
1 USD in Million
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
153 352 725
Net sales (USD)
16 527 400
Number of employees
130
Sales / Employee (USD)
127 134
Free-Float
99,1%
Free-Float capitalization (USD)
151 955 258
Avg. Exchange 20 sessions (USD)
16 062 447
Average Daily Capital Traded
10,5%
EPS & Dividend